Dr. Raetz received her medical degree and completed residency training at the University of Wisconsin. She completed a fellowship in Pediatric Hematology-Oncology at the University of Utah and was a member of the faculty from 1998 to 2002. Dr. Raetz returned to the faculty of the University of Utah in 2014, where she is a Professor in the Division of Pediatric Hematology-Oncology. She is board-certified in Pediatric Hematology-Oncology. Dr. Raetz’s clinical interests include the treatment of all pediatric cancers and hematologic disorders, with an emphasis on acute lymphoblastic leukemia (ALL) and lymphoma. She serves as the Medical Director of the High Risk Leukemia and Lymphoma Program. She is also actively involved in developing therapy for adolescents and young adults (AYAs) with ALL. Dr. Raetz’s research focuses on clinical and translational studies in ALL and she is an active member of the Children’s Oncology Group and Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium. Dr. Raetz serves on several committees within the Huntsman Cancer Institute and is the chair of the Data and Safety Monitoring Committee.

Acute Lymphoblastic Leukemia